Neuropeptide Y and hypertension

Area of Science:

• Cardiovascular Physiology
• Molecular Biology
• Hypertension Research

Background:

• Neuropeptide Y (NPY) is a key cotransmitter in the sympathetic nervous system.
• NPY exhibits potent vasoconstrictive properties, influencing vascular tone.
• Elevated NPY levels are observed in severe hypertension.

Purpose of the Study:

• To investigate the role of NPY in vascular smooth muscle cell (VSMC) proliferation.
• To identify the receptor subtypes and signaling pathways involved in NPY-mediated VSMC growth.
• To assess the impact of NPY and other sympathetic cotransmitters on VSMC growth in hypertensive patients.

Main Methods:

• Cultured human vascular smooth muscle cells were treated with NPY.
• Y1-receptor mediated effects were assessed using specific antagonists.
• Pertussis toxin was used to investigate Gi/G(o)-coupled signaling pathways.
• Mitogenic effects of NPY, noradrenaline, and ATP were compared to fetal calf serum.

Main Results:

• NPY significantly stimulated DNA synthesis, cell number, and protein production in human VSMCs via the Y1-receptor.
• A Gi/G(o)-coupled pathway mediated the mitogenic effects of NPY, as evidenced by pertussis toxin inhibition.
• NPY potentiated the mitogenic effects of noradrenaline and adenosine 5'-triphosphate (ATP).
• Circulating plasma NPY levels were elevated in severe hypertension patients, persisting after treatment.

Conclusions:

• NPY, noradrenaline, and ATP act as potent stimulators of vascular smooth muscle cell growth.
• The Y1-receptor and associated Gi/G(o)-signaling pathways mediate NPY's mitogenic effects on VSMCs.
• Elevated plasma NPY in hypertension suggests its involvement in vascular regulation and pathophysiology.